Cite
HARVARD Citation
Demyanets, S. et al. (2018). The JAK2 blocker TG101209 is a potent inhibitor of clonogenic progenitor cell growth in patients with chronic myeloid leukaemia. British journal of haematology. pp. 137-139. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Demyanets, S. et al. (2018). The JAK2 blocker TG101209 is a potent inhibitor of clonogenic progenitor cell growth in patients with chronic myeloid leukaemia. British journal of haematology. pp. 137-139. [Online].